TY - JOUR
T1 - Willingness to pay in dermatology
T2 - Assessment of the burden of skin diseases
AU - Seidler, Anne M.
AU - Bayoumi, Ahmed M.
AU - Goldstein, Mary K.
AU - Cruz, Ponciano D
AU - Chen, Suephy C.
N1 - Funding Information:
We acknowledge Calvin McCall who assisted heavily on this project, Emir Veledar for his input in the statistical analyses, and Kent Aftergut, Shenara Sexton, and Seaver Soon for their contributions to the data acquisition. This project was supported in part from the NIH/NIA 5 RO1 AG15110, “Disutility of Functional Limitation in the Elderly,” an American Skin Association Health Services Research Grant, and an Emory Skin Disease Research Center Pilot and Feasibility grant (no. P30AR42687) from the National Institute on Arthritis and Musculoskeletal and Skin Disease (NIAMS), National Institutes of Health (NIH). SCC was supported in part by a Mentored Patient Oriented Career Development Award (no. K23AR02185–01A1) from NIAMS, NIH, and by an American Skin Association David Martin Carter Research Scholar Award. During the time of data procurement, SCC was funded by a National Research Service Award (T32 HS00028) from the Agency for Healthcare Research and Quality. Views expressed are those of the authors and not necessarily those of the Department of Veterans Affairs.
PY - 2012/7
Y1 - 2012/7
N2 - Willingness to pay (WTP) is a monetary, preference-based, burden-of-disease measure with a potential role in dermatology, where many conditions are temporary and/or mild, and many treatments are inexpensive and one might be able to imagine paying out of pocket. We assessed construct validity by interviewing 254 consecutive dermatology patients at Stanford Medical Center, Grady Hospital, and Parkland Hospital. Instruments asked about an individual's own health status and elicited WTP, time-trade-off (TTO) utilities, and health status quality of life (QOL). We measured WTP cure (short treatment course to eliminate disease) and WTP control (lifelong medication). Our data indicate greater construct validity in non-Medicaid (n=163) than Medicaid (n=91) patients. Non-Medicaid subjects had greater WTP as percent of income for cure (median: 2%) than control (median: 1.6%), P<0.01; Medicaid WTP amounts for control and cure did not differ. Non-Medicaid subjects with verrucae had little QOL impact, no measurable burden by TTO, and a correspondingly low WTP. Medicaid subjects with basal cell carcinoma had a strong, negative QOL impact and high burden by TTO, but had relatively moderate WTP. WTP appears promising in certain income categories. More studies are needed for conclusions about specific diagnoses.
AB - Willingness to pay (WTP) is a monetary, preference-based, burden-of-disease measure with a potential role in dermatology, where many conditions are temporary and/or mild, and many treatments are inexpensive and one might be able to imagine paying out of pocket. We assessed construct validity by interviewing 254 consecutive dermatology patients at Stanford Medical Center, Grady Hospital, and Parkland Hospital. Instruments asked about an individual's own health status and elicited WTP, time-trade-off (TTO) utilities, and health status quality of life (QOL). We measured WTP cure (short treatment course to eliminate disease) and WTP control (lifelong medication). Our data indicate greater construct validity in non-Medicaid (n=163) than Medicaid (n=91) patients. Non-Medicaid subjects had greater WTP as percent of income for cure (median: 2%) than control (median: 1.6%), P<0.01; Medicaid WTP amounts for control and cure did not differ. Non-Medicaid subjects with verrucae had little QOL impact, no measurable burden by TTO, and a correspondingly low WTP. Medicaid subjects with basal cell carcinoma had a strong, negative QOL impact and high burden by TTO, but had relatively moderate WTP. WTP appears promising in certain income categories. More studies are needed for conclusions about specific diagnoses.
UR - http://www.scopus.com/inward/record.url?scp=84862808843&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862808843&partnerID=8YFLogxK
U2 - 10.1038/jid.2012.50
DO - 10.1038/jid.2012.50
M3 - Article
C2 - 22418874
AN - SCOPUS:84862808843
SN - 0022-202X
VL - 132
SP - 1785
EP - 1790
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 7
ER -